Molecular Biology News and Research

RSS

Molecular biology is the study of biology at a molecular level. The field overlaps with other areas of biology and chemistry, particularly genetics and biochemistry. Molecular biology chiefly concerns itself with understanding the interactions between the various systems of a cell, including the interactions between DNA, RNA and protein biosynthesis as well as learning how these interactions are regulated.

Enzo Biochem first quarter total revenues increase 2% to $25.7 million

Enzo Biochem, Inc. today reported improved sequential results for the first fiscal quarter ended October 31, 2010, the result of recent programs to reduce expenses, consolidate activities and expand operations.

13 Dec 2010

ORNL's software scans molecular databases, may help scientists to develop new drug treatments

A quicker and cheaper technique to scan molecular databases developed at the Department of Energy's Oak Ridge National Laboratory could put scientists on the fast track to developing new drug treatments.

13 Dec 2010

Research programs embody the promise of anti-aging medicine.

Sometimes the value of research lies as much in exposing false remedies as in discovering true breakthroughs. Scientists at the country's first school of gerontology and in laboratories around the University of Southern California do both, mindful of their responsibility to a society focused on healthful aging.

13 Dec 2010

Haitian cholera pathogen closely related to 'El Tor O1' variant from South Asia

Scientists from Pacific Biosciences of California, Inc. and Harvard Medical School have successfully employed single molecule, real-time (SMRT™) DNA sequencing technology to rapidly characterize the pathogen responsible for the recent deadly cholera epidemic in Haiti. Published online Thursday in the New England Journal of Medicine, the results provide the first whole genome sequence analysis and most detailed genetic profile to date of the Haitian Vibrio cholerae outbreak strain.

10 Dec 2010

Anchor Therapeutics announces publication describing pepducin technology as novel approach to target GPCR

Anchor Therapeutics today announced the publication of new research in the Proceedings of the National Academy of Sciences USA. The paper describes the identification and characterization of a pepducin-based allosteric agonist that targets CXCR4, a chemokine G protein-coupled receptor found on hematopoietic stem cells and other bone marrow-derived cells.

9 Dec 2010

Size exclusion chromatography illuminates protein crystallization

Understanding membrane protein crystallization is one of the main goals of molecular biology studies aimed at the structural characterization of proteins.

From Malvern Panalytical 7 Dec 2010

Screening for CCDC40 gene mutations may help determine risk for congenital heart defects

A gene that can cause congenital heart defects has been identified by a team of scientists, including a group from Princeton University. The discovery could lead to new treatments for those affected by the conditions brought on by the birth defect.

7 Dec 2010

Research findings could provide breakthrough for development of effective therapies for NSCLC

Research at Virginia Commonwealth University Massey Cancer Center led by Charles E. Chalfant, Ph.D., associate professor of biochemistry and molecular Biology, discovered a previously unknown mechanism in non-small cell lung cancer cells that contributes to their ability to maintain and grow tumors. Narrowing in on this mechanism could provide a breakthrough for the development of effective therapies for NSCLC and other cancers.

4 Dec 2010

Euro-BioImaging project to provide European scientists with imaging infrastructure facilities

Euro-BioImaging, a project which launches its preparatory phase today, aims to provide scientists throughout Europe with open access to state-of-the-art imaging technologies at all levels of biological and biomedical research, from bench to bedside.

3 Dec 2010

UCLA findings could lead to enhanced health supplements, progress on Parkinson's

The discovery by UCLA biochemists of a new method for preventing oxidation in the essential fatty acids of cell membranes could lead to a new class of more effective nutritional supplements and potentially help combat neurodegenerative disorders such as Parkinson's disease and perhaps Alzheimer's.

3 Dec 2010

Research: Environmental bacteria compromises effectiveness of BCG vaccine

A new discovery may explain why a tuberculosis vaccine is not as effective for some people as anticipated, and potentially explains why other vaccines do not work as well for some as they do for others.

2 Dec 2010

UMDNJ experts to discuss IOM guidelines on vitamin D

For media covering the new Institute of Medicine (IOM) guidelines on vitamin D, several experts at the University of Medicine and Dentistry of New Jersey (UMDNJ) are available for comment. The new guidelines updated the dietary reference intakes (DRIs) that the IOM established more than a decade ago and represent a significant change from previous limits.

2 Dec 2010

LabCorp completes Genzyme Genetics acquisition

Laboratory Corporation of America® Holdings today announced the successful completion of its acquisition of Genzyme Genetics, a business unit of Genzyme Corp., in an all cash transaction valued at $925 million. Net of expected income tax benefits, less acquisition-related expenses, the acquisition has a net cash cost to LabCorp of approximately $795 million.

2 Dec 2010

Research could lead to new drug treatment for metabolic diseases

A team of Harvard School of Public Health (HSPH) scientists report finding a molecular "switch" that can "turn off" some cellular processes that are protective against aging and metabolic diseases. While more research is needed, the findings may open doors for new drug treatments to halt or slow development of metabolic diseases like type 2 diabetes or heart disease. The research findings appear in the December 1, 2010 issue of Cell Metabolism.

1 Dec 2010

USC purchases WaferGen SmartChip system for Molecular Pathways and Drug Discovery center

WaferGen Biosystems, Inc., a leading developer of state-of-the-art genomic analysis systems, today announced that the University of Southern California (USC) has purchased the WaferGen SmartChip system for its USC Center for Molecular Pathways and Drug Discovery to discover and validate biomarkers for pancreatic and colorectal cancer applications to expedite the development of a cancer therapy. USC purchased a solution that includes the SmartChip platform and validated gene panels for biomarker profiling.

1 Dec 2010

Scientists identify signaling pathway and receptor for thymosin beta 4

RegeneRx Biopharmaceuticals, Inc. nnounced that scientists have identified a long sought-after extracellular signaling pathway and receptor for thymosin beta 4 (Tβ4). The observation that Tβ4 increases cell surface ATP (energy produced by cells), could explain its ability to protect and regenerate tissue after ischemic injury and hypoxia (oxygen deficiency).

30 Nov 2010

New novel explores conflicts between need for scientific truth and drive for commercial success

Research scientist Jennifer Rohn's newly released novel, The Honest Look, set in a start-up biotechnology company, explores conflicts between the need for scientific truth and the drive for commercial success.

30 Nov 2010

Life Technologies launches Qubit 2.0 Fluorometer for molecular biology research

Life Technologies Corporation, a provider of innovative life science solutions, today announced the launch of its next-generation Qubit® 2.0 Fluorometer specifically for molecular biology researchers who work with precious samples and perform applications that require a large financial or time investment. The new system quantitates DNA, RNA and protein with accuracy, sensitivity, speed and ease-of-use.

29 Nov 2010

Superantigens can disrupt immune system, can cause more illnesses

Superantigens, the toxins produced by staphylococcus bacteria, are more complex than previously believed, reveals a team of researchers from the University of Gothenburg in an article published today in the scientific journal Nature Communications. Their discovery shows that the body's immune system can cause more illnesses than realised.

29 Nov 2010

Dr. Yves DeClerck honored as first recipient of Richard Call Family Endowed Chair

Yves A. DeClerck, MD, professor of Pediatrics, Biochemistry and Molecular Biology at the Keck School of Medicine of the University of Southern California, has been inducted as the inaugural holder of the Richard Call Family Endowed Chair in Pediatric Research Innovation.

24 Nov 2010

Molecular Biology News and Research

Further Reading

Enzo Biochem first quarter total revenues increase 2% to $25.7 million

ORNL's software scans molecular databases, may help scientists to develop new drug treatments

Research programs embody the promise of anti-aging medicine.

Haitian cholera pathogen closely related to 'El Tor O1' variant from South Asia

Anchor Therapeutics announces publication describing pepducin technology as novel approach to target GPCR

Size exclusion chromatography illuminates protein crystallization

Screening for CCDC40 gene mutations may help determine risk for congenital heart defects

Research findings could provide breakthrough for development of effective therapies for NSCLC

Euro-BioImaging project to provide European scientists with imaging infrastructure facilities

UCLA findings could lead to enhanced health supplements, progress on Parkinson's

Research: Environmental bacteria compromises effectiveness of BCG vaccine

UMDNJ experts to discuss IOM guidelines on vitamin D

LabCorp completes Genzyme Genetics acquisition

Research could lead to new drug treatment for metabolic diseases

USC purchases WaferGen SmartChip system for Molecular Pathways and Drug Discovery center

Scientists identify signaling pathway and receptor for thymosin beta 4

New novel explores conflicts between need for scientific truth and drive for commercial success

Life Technologies launches Qubit 2.0 Fluorometer for molecular biology research

Superantigens can disrupt immune system, can cause more illnesses

Dr. Yves DeClerck honored as first recipient of Richard Call Family Endowed Chair

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest Life Science News